These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 17414526)
1. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model. Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents. Henn C; Satzl S; Christoph P; Kurz P; Radeleff B; Stampfl U; Stampfl S; Berger I; Richter GM J Vasc Interv Radiol; 2008 Mar; 19(3):427-37. PubMed ID: 18295704 [TBL] [Abstract][Full Text] [Related]
3. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model. Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906 [TBL] [Abstract][Full Text] [Related]
4. Reduction of late in-stent stenosis in a porcine coronary artery model by cobalt chromium stents with a nanocoat of polyphosphazene (Polyzene-F). Stampfl U; Sommer CM; Thierjung H; Stampfl S; Lopez-Benitez R; Radeleff B; Berger I; Richter GM Cardiovasc Intervent Radiol; 2008; 31(6):1184-92. PubMed ID: 18704573 [TBL] [Abstract][Full Text] [Related]
5. A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis. Richter GM; Stampfl U; Stampfl S; Rehnitz C; Holler S; Schnabel P; Grunze M Invest Radiol; 2005 Apr; 40(4):210-8. PubMed ID: 15770139 [TBL] [Abstract][Full Text] [Related]
6. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model. Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019 [TBL] [Abstract][Full Text] [Related]
7. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model. Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735 [TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries. Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890 [TBL] [Abstract][Full Text] [Related]
9. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624 [TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model. Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137 [TBL] [Abstract][Full Text] [Related]